Company Profile

Heart disease, stroke, diabetic foot ulcers, Alzheimer’s disease, Parkinson’s disease and more: Can these disorders be treated or even cured with angiogenesis? Zhittya Genesis Medicine (ZGM) is a Biopharmaceutical company, developing for FDA approval, a biological drug which triggers angiogenesis and neurogenesis. Does ZGM have possible treatment for diseases that kill over 50% of the people in the world?

Web site:

Corporate Speaker

Jack Jacobs Zhittya

Jack Jacobs, Ph.D.

President and Chief Scientific Officer

Dr. Jacobs received his BS degree from Davidson College and a Ph.D. in molecular biology from Washington University, St. Louis. He has been involved in the healthcare industry for over 25 years and has extensive expertise in supervising drug manufacturing operations and the design and implementation of preclinical animal trials and US FDA-authorized clinical trials. He started a new department of Biological Chemistry at Merck and for 15 years worked with Mr. Montano as CardioVascular BioTherapeutics’ Chief Scientific Officer where he oversaw FDA-authorized clinical trials in which FGF-1 was tested in a number of medical indications, including coronary artery disease, diabetic foot ulcers and peripheral artery disease. He also oversaw the manufacturing of clinical lots of FGF-1 that were used in those clinical studies.